Fifteen warning letters issued 25 November by the US Food and Drug Administration reference a mix of cannabidiol (CBD)-infused products styled as dietary supplements and cosmetics, but according to the agency, all are unapproved and misbranded drugs.
The FDA has been exploring potential pathways for dietary supplements containing CBD to be marketed lawfully in the states under...





